• Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
    Nov 21 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.

    Show more Show less
    5 mins
  • Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
    Nov 7 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson’s, and the role of cholesterol overload in ALS progression and disease risk.

    Show more Show less
    4 mins
  • Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
    Oct 17 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.

    This Podcast is being Sponsored by LocumTenens.com

    Show more Show less
    5 mins
  • Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
    Oct 3 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department.

    This Podcast is being Sponsored by LocumTenens.com

    Show more Show less
    5 mins
  • Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
    Sep 19 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.

    Show more Show less
    5 mins
  • Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
    Sep 5 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights a new workgroup’s recommendations on biomarkers for diagnosing Alzheimer’s, AI’s ability to track Parkinson’s severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.

    Show more Show less
    5 mins
  • Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
    Aug 15 2024

    In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.

    Show more Show less
    5 mins
  • Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
    Jul 31 2024

    In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.

    Show more Show less
    5 mins